We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

PPD to Discover Biomarkers for PDL BioPharma

News  
Published: May 3, 2006
 
Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above. ✖

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy
Read time: Less than a minute

PPD, Inc. has announced it has signed an agreement by which it will perform comprehensive molecular profiling to discover biomarkers for PDL BioPharma, Inc.

Under the terms of the agreement, PPD's biomarker discovery sciences group will examine specified sample sets utilizing DeepLook™ analysis, its proprietary integrated platform for mass spectrometry-based discovery of biomarkers.

"Identification and implementation of biomarkers can accelerate clinical trials by improving diagnosis, patient selection, and monitoring of disease progression and therapeutic response," said Howard Schulman, vice president of PPD's biomarker discovery sciences.

"We look forward to working with PDL BioPharma to develop biomarkers for its clinical development programs."

Related Topic Pages
Mass Spectrometry
Biomarkers
Advertisement
Advertisement
Advertisement
Decoratvive background images
Never miss a story
with the Breaking Science News daily newsletter